https://www.selleckchem.com/pr....oducts/blasticidin-s
4% vs 5.3%, p less then 0.001). The presence of robust collaterals was associated with higher rates of normal or mildly impaired left ventricular function (83.5% vs 63.2%, p less then 0.0001) and lower in-hospital mortality (2.1% vs 7.6%, p less then 0.0001). After correcting for left ventricular function, collateral recruitment was not an independent predictor of mortality. In conclusion, in patients presenting with STEMI, the presence of robust coronary collaterals appears to be associated with improved left ventricular func
Beğen
Yorum Yap
Paylaş
